Clinical Trial Update: Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and potential efficacy of combining ZEN003694 with abemaciclib in adults and 12-17-year-old pediatric patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Malignant Solid Tumor
• Nut Carcinoma

Drugs mentioned

• Abemaciclib (abemaciclib)
• ZEN003694

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 1 | Status: RECRUITING